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Purpose: to assess the trends of self-reported prevalence of cardiovascular risk factors (CV RFs: 
hypertension, dyslipidaemia, diabetes) and their management for period 1992 to 2007 in the Swiss 
population. 
Methods: four National health interview surveys conducted between 1992 and 2007 in 
representative samples of the Swiss population (63,782 subjects overall). Self-reported CV RFs 
prevalence, treatment and controllevels were computed after weighting. Weights were calculated 
by raking ratio such that the marginal distribution of the weighted totals conforms to the marginal 
distribution of the targeted population. Multivariate analysis adjusted on age, sex, education, 
nationality and SMI was conducted using logistic regression. 
Results: prevalence of ail CV RFs increased between 1992 and 2007, see table. Although the 
self-reported prevalence of treatment among subjects with CV RFs increased, and this was 
confirmed by multivariate analysis: OR for hypocholesterolaemic treatment relative to 1992: 0.64 
[0.52-0.78]; 1.39 [1.18-1.65] and 2.00 [1.69-2.36] for 1997, 2002 and 2007, respectively. Still, in 
2007, circa 40% of hypertensive, 60% of dyslipidaemic and 50% of diabetic subjects weren't 
treated. Conversely, an adequate control of CV RFs was reported by treated subjects, with an 
increase during the study period. This increase was confirmed by multivariate analysis (not 
shown). 
Conclusion: the self-reported prevalence of hypertension, dyslipidaemia and diabetes increased 
between 1992 and 2007 in the Swiss population. Despite a good control of treated subjects, still a 
significant percentage of subjects with CV RFs are not treated. 
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